Standard 2.9.5 Food for special medical purposes

Note 1 This instrument is a standard under the Food Standards Australia New Zealand Act 1991 (Cth). The standards together make up the Australia New Zealand Food Standards Code. See also section 1.1.1—3.

Note 2 The provisions of the Code that apply in New Zealand are incorporated in, or adopted under, the Food Act 2014 (NZ). See also section 1.1.1—3.

Division 1 Preliminary

2.9.5—1 Name

  This Standard is Australia New Zealand Food Standards Code – Standard 2.9.5 – Food for special medical purposes.

 Note Commencement:
This Standard commences on 1 March 2016, being the date specified as the commencement date in notices in the Gazette and the New Zealand Gazette under section 92 of the Food Standards Australia New Zealand Act 1991 (Cth). See also section 93 of that Act.

2.9.5—2 Definitions

Note 1 Section 1.1.2—5 (Definition of food for special medical purposes) provides as follows:

 (1) In this Code:

  food for special medical purposes means a food that is:

 (a) specially formulated for the dietary management of individuals:

 (i) by way of exclusive or partial feeding, who have special medically determined nutrient requirements or whose capacity is limited or impaired to take, digest, absorb, metabolise or excrete ordinary food or certain nutrients in ordinary food; and

 (ii) whose dietary management cannot be completely achieved without the use of the food; and

 (b) intended to be used under medical supervision; and

 (c) represented as being:

 (i) a food for special medical purposes; or

 (ii) for the dietary management of a disease, disorder or medical condition.

 (2) Despite subsection (1), a food is not food for special medical purposes if it is: 

 (a) an infant formula product; or

 (b) a food specially formulated for the dietary management of overweight and obesity and which is not a *very low energy food.

Note 2 In this Code (see section 1.1.2—2):

 inner package, in relation to a food for special medical purposes, means an individual package of the food that:

 (a) is contained and sold within another package that is labelled in accordance with section 2.9.5—9; and

 (b) is not designed for individual sale, other than a sale by a responsible institution to a patient or resident of the responsible institution.

 Example An example of an inner package is an individual sachet (or sachets) of a powdered food contained within a box that is fully labelled, being a box available for retail sale.

 responsible institution means a hospital, hospice, aged care facility, disability facility, prison, boarding school or similar institution that is responsible for the welfare of its patients or residents and provides food to them.

Note 3 In this Standard (see section 1.1.2—2), a reference to a package does not include a reference to a plate, cup, tray or other food container in which food for special medical purposes is served by a responsible institution to a patient or resident of the responsible institution.

Note 4 In this Code (see section 1.1.2—2):

 very low energy diet means a range of food for special medical purposes specially formulated for the dietary management of overweight and obesity and which provide the sole source of nutrition when consumed according to the directions for use on the label.

 very low energy food means a food for special medical purposes produced for consumption as part of a *very low energy diet.

 

2.9.5—3 Application of other standards

  The following provisions do not apply to food for special medical purposes:

 (a) paragraphs 1.1.1—10(6)(b) (foods used as nutritive substances) and 1.1.1—10(6)(f) (novel foods); and

 (b) unless the contrary intention appears, Part 1.2 of Chapter 1 (labelling and other information requirements); and

 (c) Standard 2.9.2, Standard 2.9.3 or Standard 2.9.4 (food for infants, formulated meal replacements and formulated supplementary foods, formulated supplementary sports foods).

2.9.5—4 Claims must not be therapeutic in nature

  A claim in relation to food for special medical purposes must not:

 (a) refer to the prevention, diagnosis, cure or alleviation of a disease, disorder or condition; or

 (b) compare the food with a good that is:

 (i) represented in any way to be for therapeutic use; or

 (ii) likely to be taken to be for therapeutic use, whether because of the way in which the good is presented or for any other reason.

Division 2 Sale of food for special medical purposes

2.9.5—5 Restriction on the persons by whom, and the premises at which, food for special medical purposes may be sold

 (1) A food for special medical purposes must not be sold to a consumer, other than from or by:

 (a) a medical practitioner or dietitian; or

 (b) a medical practice, pharmacy or responsible institution; or

 (c) a majority seller of that food for special medical purposes.

 (2) In this section:

medical practitioner means a person registered or licensed as a medical practitioner under legislation in Australia or New Zealand, as the case requires, for the registration or licensing of medical practitioners.

majority seller: a person is a majority seller of a food for special medical purposes during any 24 month period if:

 (a) during the period, the person sold that food for special medical purposes to medical practitioners, dietitians, medical practices, pharmacies or responsible institutions; and

 (b) the sales mentioned in paragraph (a) represent more than one half of the total amount of that food for special medical purposes sold by the person during the period.

Division 3 Composition

2.9.5—6 Permitted forms of particular substances

 (1) The following substances may be added to food for special medical purposes:

 (a) a substance that is listed in Column 1 of the table to section S29—20 and that is in a corresponding form listed in Column 2 of that table;

 (b) a substance that is listed in Column 1 of the table to section S29—23 and that is in a corresponding form listed in Column 2 of that table;

 (c) any other substance, regardless of its form, that is permitted under this Code to be added to a food, if that substance is added in accordance with any applicable requirement of this Code.

 (2) If a provision of this Code limits the amount of a substance referred to in paragraph (1)(a) or (b) that may be added to a food, that limit does not apply in relation to food for special medical purposes.

2.9.5—7 Compositional requirements for food represented as being suitable for use as sole source of nutrition

 (1) If food for special medical purposes is represented as being suitable for use as a sole source of nutrition, the food must contain:

 (a) not less than the minimum amount, as specified in column 2 of the table to section S29—21, of each vitamin, mineral and electrolyte listed in Column 1 of that table; and

 (b) if applicable, not more than the maximum amount, as specified in Column 3 of that table, of each vitamin and mineral listed in Column 1.

 (2) However, the food is not required to comply with subsection (1) to the extent that:

 (a) a variation from a maximum or minimum amount is required for a particular medical purpose; and

 (b) the labelling complies with subparagraph 2.9.5—10(1)(g)(ii).

 (3) Subsection (1) does not apply to a *very low energy food.

Division 4 Labelling

2.9.5—8 Labelling and related requirements

 (1) If a food for sale consisting of food for special medical purposes is not in a package:

 (a) the food for sale must either *bear a label, or have labelling that is displayed in connection with its sale, with the information relating to irradiated foods (see section 1.5.3—9); and

 (b) there is no other labelling requirement under this Code.

 (2) If the food for sale is in a package, it is required to *bear a label that complies with section 2.9.5—9.

 (3) If the food for sale is in an *inner package:

 (a) the inner package is required to *bear a label that complies with section 2.9.5—16; and

 (b) there is no labelling requirement under this Code for any other packaging associated with the food for sale.

 (4) If the food for sale is in a *transportation outer:

 (a) the transportation outer or package containing the food for sale is required to *bear a label that complies with section 2.9.5—17; and

 (b) there is no labelling requirement under this Code for any other packaging associated with the food for sale.

2.9.5—9 Mandatory labelling information

 (1) Subject to this section, the label that is required for food for special medical purposes must state the following information in accordance with the provision indicated:

 (a) a name or description sufficient to indicate the true nature of the food (see section 1.2.2—2);

 (b) lot identification (see section 1.2.2—3);

 (c) if the sale of the food for sale is one to which Division 2 or Division 3 of Standard 1.2.1 applies—information relating to irradiated food (see section 1.5.3—9);

 (d) any required advisory statements, *warning statements, other statements, and declarations (see section 2.9.5—10);

 (e) information relating to ingredients (see section 2.9.5—11);

 (f) date marking information (see section 2.9.5—12);

 (g) directions for the use or the storage of the food, if the food is of such a nature to require such directions for health or safety reasons;

 (h) nutrition information (see section 2.9.5—13);

 (i) if appropriate, the information required by subsection 2.9.5—14(4) or 2.9.5—15(5).

 (2) The label for a food for special medical purposes that is a *very low energy food must also state the recommended daily quantity of all very low energy foods to be consumed in order to provide the sole source of nutrition.

 (3) The label must comply with Division 6 of Standard 1.2.1.

 

2.9.5—10 Mandatory statements and declarations—food for special medical purposes

 (1) For paragraph 2.9.5—9(1)(d), the following statements are required:

 (a) a statement to the effect that the food must be used under medical supervision;

 (b) a statement indicating, if applicable, any precautions and contraindications associated with consumption of the food;

 (c) a statement indicating the medical purpose of the food, which may include a disease, disorder or medical condition for which the food has been formulated;

 (d) a statement describing the properties or characteristics which make the food appropriate for the medical purpose indicated in paragraph (c);

 (e) if the food has been formulated for a specific age group—a statement to the effect that the food is intended for persons within the specified age group;

 (f) a statement indicating whether or not the food is suitable for use as a sole source of nutrition;

 (g) if the food is represented as being suitable for use as a sole source of nutrition:

 (i) a statement to the effect that the food is not for parenteral use; and

 (ii) if the food has been modified to vary from the compositional requirements of section 2.9.5—7 such that the content of one or more nutrients falls short of the prescribed minimum, or exceeds the prescribed maximum (if applicable), and the food is not a *very low energy food:

 (A) a statement indicating the nutrient or nutrients which have been modified; and

 (B) unless provided in other documentation about the food—a statement indicating whether each modified nutrient has been increased, decreased, or eliminated from the food, as appropriate,

 (h) if the food is a *very low energy food:

 (i) a statement to the effect that it is important to maintain adequate daily fluid intake while using the food; and

 (ii) a statement to the effect that the food is not recommended for pregnant, nursing, or lactating women or use by infants, children, adolescents and elderly, other than under medical supervision; and

 (iii) a statement indicating that the food is suitable for use as a sole source of nutrition when consumed according to the directions for use on the label.

 

 (2) For paragraph 2.9.5—9(1)(d), the required advisory statements and declarations are any that are required by:

  (a) items 1, 4, 6 or 9 of the table to section S9—2; or

  (b) subsection 1.2.3—2(2); or

   (c)   section 1.2.3—4.

  (3) For paragraph 2.9.5—9(1)(d), the *warning statement referred to in section 1.2.3—3, if applicable, is required.

2.9.5—11 Information relating to ingredients—food for special medical purposes

  For paragraph 2.9.5—9(1)(e), the information relating to ingredients is:

 (a) a statement of ingredients; or

 (b) information that complies with Articles 18, 19, 20 of Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers; or

 (c) information that complies with 21 CFR § 101.4.

 

2.9.5—12 Date marking information—food for special medical purposes

 (1) For paragraph 2.9.5—9(1)(f), the required date marking information is date marking information in accordance with Standard 1.2.5.

 (2) Despite subsection (1), for subparagraph 1.2.5—5(2)(a)(ii), the words ‘Expiry Date’, or similar words, may be used on the label.

2.9.5—13 Nutrition information—food for special medical purposes

 (1) For paragraph 2.9.5—9(1)(h), the nutrition information required for a food that is not a *very low energy food is the following, expressed per given amount of the food:

 (a) the minimum or *average energy content; and

 (b) the minimum amount or *average quantity of:

 (i) protein, fat and carbohydrate; and

 (ii) any vitamin, mineral or electrolyte that has been *used as a nutritive substance in the food; and

 (iii) any substance listed in the table to section S29—20 that has been *used as a nutritive substance in the food; and

 (iv) subject to paragraph 2.9.5—9(1)(i), any other substance in respect of which a *nutrition content claim has been made.

 (2) For paragraph 2.9.5—9(1)(h), the nutrition information required for a food that is a *very low energy food is the following:

 (a) the *average quantity of that food per serving; and

 (b) the *average energy content per serving; and

 (c) the minimum amount or average quantity per serving of:

 (i) protein, fat and carbohydrate; and

 (ii) linoleic acid and α-linolenic acid; and

 (iii) any substance listed in the table to section S29—22 that has been *used as a nutritive substance in the food; and

 (iv) any other vitamin, mineral or electrolyte that has been *used as a nutritive substance in the food; and

 (v) subject to paragraph 2.9.5—9(1)(i), any other substance in respect of which a *nutrition content claim has been made.

2.9.5—14 Claims in relation to lactose content

 (1) A claim in relation to the lactose content of a food for special medical purposes must not be made unless expressly permitted by this section.

 (2) A claim to the effect that a food for special medical purposes is lactose free may be made if the food for sale contains no detectable lactose.

 (3) A claim to the effect that a food for special medical purposes is low lactose may be made if the food for sale contains not more than 2 g of lactose per 100 g of the food.

 (4) If a claim in relation to the lactose content of a food for special medical purposes is made, the information required is the *average quantity of the lactose and galactose in the food, expressed per given quantity of the food.

 Note See paragraph 2.9.5—9(1)(i).

2.9.5—15 Claims in relation to gluten content

 (1) A claim in relation to the *gluten content of a food for special medical purposes is prohibited unless expressly permitted by this section.

 (2) A claim to the effect that a food for special medical purposes is gluten free may be made if the food contains:

 (a) no detectable gluten; and

 (b) no oats or oat products; and

 (c) no cereals containing *gluten that have been malted, or products of such cereals.

 (3) A claim to the effect that a food for special medical purposes has a low gluten content may be made if the food contains no more than 20 mg *gluten per 100 g of the food.

 (4) A claim to the effect that a food for special medical purposes contains *gluten or is high in gluten may be made.

 (5) If a claim is made in relation to the *gluten content of a food for special medical purposes, the information required is the *average quantity of the gluten in the food, expressed per given amount of the food.

 Note See paragraph 2.9.5—9(1)(i).

 

2.9.5—16 Labelling requirement—food for special medical purposes in inner package

 (1) The label on an *inner package that contains food for special medical purposes must state the following information in accordance with the provision indicated:

 (a) a name or description sufficient to indicate the true nature of the food (see section 1.2.2—2);

 (b) lot identification (see section 1.2.2—3);

 (c) any declaration that is required by section 1.2.3—4;

 (d) date marking information (see section 2.9.5—12).

 (2) The label must comply with Division 6 of Standard 1.2.1.

 (3) To avoid doubt, this section continues to apply to the label on the *inner package if a *responsible institution subsequently supplies the inner package to a patient or resident of the responsible institution.

2.9.5—17 Labelling requirement—food for special medical purposes in transportation outer

 (1) If packages of food for special medical purposes are contained in a transportation outer, the information specified in subsection (2) must be:

 (a) contained in a label on the transportation outer; or

 (b) contained in a label on a package of the food for sale, and clearly discernible through the transportation outer.

 (2) For subsection (1), the information is:

 (a) a name or description sufficient to indicate the true nature of the food (see section 1.2.2—2); and

 (b) lot identification (see section 1.2.2—3); and

 (c) unless it is provided in accompanying documentation—the name and address of the *supplier (see section 1.2.2—4).

Division 5 Very Low Energy Diets

2.9.5—18 Compositional requirements for very low energy diets

 (1) A *very low energy food must, when consumed according to the manufacturer’s directions for use, result in a diet that:

 (a) has an *average energy content of no less than 1880 kJ/day and no more than 3345 kJ/day; and

 (b) contains not less than 50 g of *available carbohydrates present within the average energy content required by paragraph (a); and

 (c) contains not less than 50 g protein per day with a nutritional quality equivalent to a protein digestibility corrected amino acid score of 1, present within the average energy content required by paragraph (a); and

 (d)  contains within the average energy content required by paragraph (a) not less than:

 (i) 3 g of linoleic acid; and

 (ii) 0.5 g of α-linolenic acid; and

 (e)  has a ratio of linoleic acid to α-linolenic acid of between 5 and 15; and

 (f) contains not less than the minimum amount per daily intake, as specified in column 2 of the table to section S29—22, of each nutrient listed in Column 1 of that table.

 (2) Despite subsection 2.9.5—6(2), L-amino acids listed in Column 2 of the table to section S29—20 may be added to a *very low energy food only in an amount necessary to improve protein quality.

 (3) For this section, protein digestibility corrected amino acid score means the score calculated and expressed in accordance with the method referred to on page 23 of the Report of the Joint FAO/WHO Expert Consultation on Protein Quality Evaluation, Bethesda, MD USA, 4-8 December 1989, FAO Food and Nutrition Paper No. 51, Food and Agriculture Organisation of the United Nations, Rome, 1991.

2.9.5—19 Prohibition on health claims in relation to very low energy foods

  A *health claim must not be made about a *very low energy food.

 

____________________

Application, saving and transitional provisions

The table below details information on application, saving or transitional provisions in instruments affecting this Standard.

 

Food Standards (Proposal P1044 – Plain English Allergen Labelling) Variation

Instrument items affected

A’ment No.

FRL registration

Gazette

Instrument’s transitional provision

Description of transitional arrangement

Item [5] of the Schedule

197

F2021L00145

24 Feb 2021

FSC138

25 Feb 2021

Clause 4

 

Clause 4 a transitional arrangement for variations to the Code made by Item [5.1], [5.2], and [5.3] of the Schedule.

 

The transition period is the period of time that commences on 25 February 2021 and ends on 25 February 2024.

 

The post-transition period is the period of time that commences 26 February 2024 and ends on 26 February 2026.

 

Subclause 4(1) provides that section 1.1.1—9 of the Code does not apply to the variations.

 

Subclause 4(2) provides that during the transition period a food product may be sold if the product complies with one of the following:

 

  1.       the Code as in force without the above variations;
  2.       the Code as amended by the above variations.

 

Subclause 4(3) provides that a food product packaged and labelled before the end of the transition period may be sold during the post-transition period if the product complies with one of the following:

 

  1.       the Code as in force without the above variations;
  2.       the Code as amended by the above variations.

 


Food Standards (Application A1230 – Very Low Energy Diets (VLED)) Variation

Items [2.1] [2.2] [2.3] [2.4] [2.5] [2.6] [2.7] [2.8] [2.9] of the Schedule

208

F2022L00733

1 June 2022

FSC 148

1 June 2022

Clause 4

 

Clause 4 of the Food Standards (Application A1230 – Very Low Energy Diets (VLED)) Variation provides a transitional arrangement for the variations to the Code made by Items [2.1] [2.2] [2.3] [2.4] [2.5] [2.6] [2.7] [2.8] [2.9] of the Schedule to that legislative instrument.

 

Subclause 4(1) provides that section 1.1.1—9 of the Code does not apply to the variations made by that instrument.

 

Subclause 4(2) provides that, during the transition period, a food product may be sold if the product complies with one of the following:

 

  1.       the Code as in force without the variations made by the instrument;
  2.       the Code as amended by the variations made by the instrument.

 

Subclause 4(3) provides that, for the purposes of the above, the transition period is the period commencing on the variation’s date of commencement and ending 36 months after the date of commencement.

 

This means that the transition period is the period of time that commences on 1 June 2022 and ends on 1 June 2025.

 

Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) Variation

Item [18] of Schedule 2

231

F2024L01151

13 Sept 2024

FSC 171

13 Sept 2024 

Clause 4

 

Clause 4 establishes a transitional arrangement for variations to the Code made by Item [18] of Schedule 2 and by the Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) Variation.

 

The transition period is the period of time that commences on 13 September 2024 and ends on 13 September 2029.

 

Subclause 4(1) provides that section 1.1.1—9 of the Code does not apply to the variations.

 

Subclause 4(2) provides that during the transition period a food product may be sold if the product complies with one of the following:

 

(a) the Code as in force without the above variations;

(b) the Code as amended by the above variations.

 

Subclause 4(3) provides that a food product that was labelled before the end of the transition period may be sold after the transition period if the product complies with one of the following:

 

(a) the Code as in force without the above variations;

(b) the Code as amended by the above variations.
 

 


Amendment History

The Amendment History provides information about each amendment to the Standard. The information includes commencement or cessation information for relevant amendments.

 

These amendments are made under section 92 of the Food Standards Australia New Zealand Act 1991 unless otherwise indicated. Amendments do not have a specific date for cessation unless indicated as such.

 

About this compilation

 

This is compilation No. 5 of Standard 2.9.5 as in force on 13 September 2024 (up to Amendment No. 231). It includes any commenced amendment affecting the compilation to that date.

 

Prepared by Food Standards Australia New Zealand on 13 September 2024.

 

Uncommenced amendments or provisions ceasing to have effect

 

To assist stakeholders, the effect of any uncommenced amendments or provisions which will cease to have effect, may be reflected in the Standard as shaded boxed text with the relevant commencement or cessation date. These amendments will be reflected in a compilation registered on the Federal Register of Legislation including or omitting those amendments and provided in the Amendment History once the date is passed.

 

 

The following abbreviations may be used in the table below:

 

ad = added or inserted am = amended

exp = expired or ceased to have effect rep = repealed

rs = repealed and substituted

 

Standard 2.9.5 was published in the Food Standards Gazette No. FSC96 on 10 April 2015 as part of Amendment 154 (F2015L00472 –- 1 April 2015) and has since been amended as follows:

 

Section affected

A’ment No.

FRL registration

Gazette

Commencement

(Cessation)

How affected

Description of amendment

2.9.5—3

157

F2015L01374

1 Sept 2015

FSC99

3 Sept 2015

1 March 2016

 

am

Removal of reference to Standard 1.1A.2 in paragraph (a).

2.9.5—3

161

F2016L00120

18 Feb 2016

FSC103

22 Feb 2016

1 March 2016

 

am

Correction of reference to Part 1.2.

2.9.5—3

168

F2017L00414

11 April 2017

FSC110

13 April 2017

 

13 April 2017

rs

Section to correct cross-references.

2.9.5—11

168

F2017L00414

11 April 2017

FSC110

13 April 2017

 

13 April 2017

am

Paragraph (b) replaced to update reference.

2.9.5—9

197

F2021L00145

24 Feb 2021

FSC138

25 Feb 2021

25 Feb 2021

am

Paragraph 2.9.5—9(1)(d) amended to include ‘declarations’.

 

For application, saving and transitional provisions, see above table.

2.9.5—10

197

F2021L00145

24 Feb 2021

FSC138

25 Feb 2021

25 Feb 2021

am

Heading for 2.9.5—10 amended and paragraph 2.9.5—10(2) amended to include ‘declarations’.

 

For application, saving and transitional provisions, see above table.

2.9.5—2

208

F2022L00733

1 June 2022

FSC148

1 Jun 2022

1 June 2022

am

Note 1 amended

 

For application, saving and transitional provisions, see above table.

 

2.9.5—2

208

F2022L00733

1 June 2022

FSC148

1 Jun 2022

1 June 2022

ad

Note 4 added

 

For application, saving and transitional provisions, see above table.

 

2.9.5—7(2)

208

F2022L00733

1 June 2022

FSC148

1 Jun 2022

1 June 2022

ad

(3) added

 

For application, saving and transitional provisions, see above table.

 

2.9.5—9(2)

208

F2022L00733

1 June 2022

FSC148

1 Jun 2022

1 June 2022

rs

Repealed and substituted (2) and (3)

 

For application, saving and transitional provisions, see above table.

 

2.9.5—10(1)(g)(ii) and g(ii)B

208

F2022L00733

1 June 2022

FSC148

1 Jun 2022

1 June 2022

am

Omitted and substituted

 

For application, saving and transitional provisions, see above table.

 

2.9.5—10(1)(g)

208

F2022L00733

1 June 2022

FSC148

1 Jun 2022

1 June 2022

ad

10(1)(h) added

 

For application, saving and transitional provisions, see above table.

 

2.9.5—13

208

F2022L00733

1 June 2022

FSC148

1 Jun 2022

1 June 2022

rs

Repealed and substituted

 

For application, saving and transitional provisions, see above table.

 

2.9.5—18

208

F2022L00733

1 June 2022

FSC148

1 Jun 2022

1 June 2022

ad

Added section 18, compositional requirements for very low energy diets

 

For application, saving and transitional provisions, see above table.

 

2.9.5—19

208

F2022L00733

1 June 2022

FSC148

1 Jun 2022

1 June 2022

ad

Added section 19. Prohibition on health claims in relation to very low energy foods

 

For application, saving and transitional provisions, see above table.

 

2.9.5—6(1)(b)

231

F2024L01151

13 Sept 2024

FSC 171

13 Sept 2024

13 September 2024

rs

Repeal ‘section S29—7’ and substitute with ‘section S29—23’.